Chun-Hao Huang

Title: The Innovative Contributions of Chun-Hao Huang

Introduction

Chun-Hao Huang is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on identifying CDK9 inhibitors, which play a crucial role in the treatment of various cancers.

Latest Patents

Chun-Hao Huang holds a patent for a method and kits for identifying CDK9 inhibitors for the treatment of cancer. This patent outlines a method of determining sensitivity to cancer treatment by assessing the presence of overexpression of MYC in a biological sample from a patient suffering from cancer. The presence of MYC overexpression indicates sensitivity to treatment by a CDK9 inhibitor, with applicable cancers including carcinoma, leukemia, and lymphoma. He has 1 patent to his name.

Career Highlights

Throughout his career, Chun-Hao Huang has worked with esteemed institutions such as Memorial Sloan Kettering Cancer Center and St. Jude Children's Research Hospital. His research has contributed to advancements in cancer therapies and has the potential to improve patient outcomes significantly.

Collaborations

Chun-Hao Huang has collaborated with notable colleagues in the field, including Scott William Lowe and Charles J Sherr. These collaborations have further enhanced his research and innovation in cancer treatment.

Conclusion

Chun-Hao Huang's work exemplifies the impact of innovative research in the medical field, particularly in cancer treatment. His patented methods and collaborations with leading institutions highlight his commitment to advancing healthcare solutions.